Showing 261 - 280 results of 3,328 for search '(( significant decrease decrease ) OR ( significant all decrease ))~', query time: 0.34s Refine Results
  1. 261
  2. 262
  3. 263

    Manhattan plot for genome-wide association study (GWAS) in a European population with depression. by Xiaomei He (795333)

    Published 2025
    “…C: Point mutations in the tail region of KIF15 significantly decreased its binding efficiency to PSD95, n = 3 (three independent experiments). …”
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269
  10. 270

    Grade system. by Zhuoyang Xia (21354186)

    Published 2025
    “…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”
  11. 271

    Literature search. by Zhuoyang Xia (21354186)

    Published 2025
    “…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”
  12. 272

    Study characteristics. by Zhuoyang Xia (21354186)

    Published 2025
    “…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”
  13. 273

    Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

    Published 2025
    “…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”
  14. 274

    Data extraction. by Zhuoyang Xia (21354186)

    Published 2025
    “…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”
  15. 275

    Cochrane Collaboration’s risk of bias tool. by Zhuoyang Xia (21354186)

    Published 2025
    “…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”
  16. 276

    <i>Kif15</i> deficiency affects the expression of excitatory postsynaptic receptors in PFC and hippocampus. by Xiaomei He (795333)

    Published 2025
    “…All the data are presented as mean±SD, *P < 0.05, **P < 0.01, two-tailed student’s t test were used for comparison between two groups, expect for the GluA1 of J, which was used as a nonparametric test.…”
  17. 277
  18. 278
  19. 279
  20. 280